Transplant Genomics ATC Luncheon Symposium

Sheraton Hotel Grand Ballroom – Level 2
Sunday, June 2, from 1:00 to 2:15

Management of Kidney Transplant Recipients with Stable Renal Function
Using TruGraf® Testing

1:00 - 1:05 Attendee Lunch & Registration
1:05 - 1:20 Opening comments
CMS reimbursement
update
Stan Rose PhD – CEO
Transplant Genomics Inc.
1:20 - 1:35 Correlation between TruGraf®
test results, graft histology and
other laboratory tests in patients
with stable renal function
Clifton Kew MD
Medical Director, Kidney &
Pancreas Transplant Program
Univ of Alabama Birmingham
Birmingham, AL
1:35 - 1:50 Utility of serial monitoring
with TruGraf testing in non-
surveillance biopsy programs
Parul Patel MD
Transplant Nephrologist
California Pacific Medical Ctr
San Francisco, CA
1:50 - 2:05 Ruling-out “silent” subclinical
rejection in kidney transplant
recipients and why it matters
John Friedewald MD
Medical Director, Kidney &
Pancreas Transplant Program
Northwestern Medicine
Chicago, IL
2:05 - 2:15 Questions & Comments Roy First MD- CMO
Transplant Genomics Inc.
www.trugraf.com
*This symposium is not part of the ATC official educational program and the sessions and content are not endorsed by ATC.